000 01606 a2200433 4500
005 20250518083002.0
264 0 _c20210118
008 202101s 0 0 eng d
022 _a1873-2607
024 7 _a10.1016/j.amepre.2019.10.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWateska, Angela R
245 0 0 _aPneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. Populations.
_h[electronic resource]
260 _bAmerican journal of preventive medicine
_c04 2020
300 _a487-495 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aBlack or African American
_xstatistics & numerical data
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCost-Benefit Analysis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMarkov Chains
650 0 4 _aPneumococcal Infections
_xeconomics
650 0 4 _aPneumococcal Vaccines
_xadministration & dosage
650 0 4 _aQuality-Adjusted Life Years
650 0 4 _aUnited States
650 0 4 _aVaccination
_xeconomics
650 0 4 _aVaccines, Conjugate
_xadministration & dosage
700 1 _aNowalk, Mary Patricia
700 1 _aLin, Chyongchiou J
700 1 _aHarrison, Lee H
700 1 _aSchaffner, William
700 1 _aZimmerman, Richard K
700 1 _aSmith, Kenneth J
773 0 _tAmerican journal of preventive medicine
_gvol. 58
_gno. 4
_gp. 487-495
856 4 0 _uhttps://doi.org/10.1016/j.amepre.2019.10.022
_zAvailable from publisher's website
999 _c30579157
_d30579157